Biohaven Ltd.
BHVN
$30.40
-$0.57-1.84%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.46M | 20.56M | 18.95M | 27.27M | 18.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 179.03M | 178.17M | 333.77M | 183.24M | 153.71M |
| Operating Income | -179.03M | -178.17M | -333.77M | -183.24M | -153.71M |
| Income Before Tax | -186.80M | -160.36M | -319.59M | -178.94M | -145.97M |
| Income Tax Expenses | 48.00K | -59.00K | 177.00K | 569.00K | -1.21M |
| Earnings from Continuing Operations | -186.84M | -160.30M | -319.77M | -179.50M | -144.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -186.84M | -160.30M | -319.77M | -179.50M | -144.76M |
| EBIT | -179.03M | -178.17M | -333.77M | -183.24M | -153.71M |
| EBITDA | -176.57M | -176.17M | -331.82M | -181.79M | -151.82M |
| EPS Basic | -1.85 | -1.70 | -3.64 | -2.20 | -1.81 |
| Normalized Basic EPS | -1.13 | -1.10 | -2.31 | -1.40 | -1.19 |
| EPS Diluted | -1.85 | -1.70 | -3.64 | -2.20 | -1.81 |
| Normalized Diluted EPS | -1.13 | -1.10 | -2.31 | -1.40 | -1.19 |
| Average Basic Shares Outstanding | 101.05M | 94.37M | 87.77M | 81.60M | 79.93M |
| Average Diluted Shares Outstanding | 101.05M | 94.37M | 87.77M | 81.60M | 79.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
